November 3, 2015 — Australian immuno-oncology company Minomic International Ltd has struck an agreement to launch the ...
Molecular Imaging
Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI. Molecular imaging includes the field of nuclear medicine, which uses very small amounts of radioactive materials, or radiopharmaceuticals, to diagnose and treat disease.
November 3, 2015 — The University of Tennessee Medical Center announced it has implemented new software aimed at ...
October 20, 2015 — In October, Siemens Healthcare debuted a host of imaging systems that enable radiation therapy (RT) ...
Technological advancements in positron emission tomography/computed tomography (PET/CT) offer both clinicians and ...
October 19, 2015 — Siemens’ PETNET Solutions Inc., a wholly owned subsidiary of Siemens Healthcare, will formulate the ...
October 14, 2015 — Gamma Medica Inc. announced the CE Mark approval allowing for the sale and distribution of the ...
October 2, 2015 — Siemens’ PETNET Solutions has received Abbreviated New Drug Application (ANDA) approval from the U.S ...
Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both. The key is the ...
September 23, 2015 — New research describes a method, tested in rats, that may someday allow healthcare providers to ...
September 23, 2015 — The World Molecular Imaging Society (WMIS) presented the first annual Commercial Innovation of the ...
They were once the kings of computed tomography (CT) — 16-slice scanners that hinted at coronary CT angiography; 64 ...
Introducing HYPERSCAN , Pencil Beam Scanning Delivery HYPERSCAN enables tumor volumes to be scanned in a matter of ...
September 18, 2015 — A recently developed drug was significantly better at detecting recurring prostate cancer in early ...
September 17, 2015 — At the National Nuclear Security Administration’s (NNSA) 2015 Mo-99 Topical Meeting, Novation ...
September 16, 2015 — A novel radiopharmaceutical probe developed at Massachusetts General Hospital (MGH) has the ...
September 14, 2015 — ImaginAb Inc. has released interim results from a Phase 2 clinical trial of IAB2M, the company's ...
September 11, 2015 — Zevacor Molecular (Zevacor), manufacturer and distributor of positron emission tomography (PET) and ...
September 11, 2015 — Westinghouse Electric Company and NorthStar Medical Radioisotopes announced a memorandum of ...
During the recent American Association of Physicists in Medicine (AAPM) conference in Anaheim, Calif., I had the ...
September 3, 2015 — Navidea Biopharmaceuticals Inc. received initial notice of award for a Fast Track Small Business ...
August 31, 2015 — NorthStar Medical Radioisotopes LLC has received approval to begin routine production of molybdenum-99 ...
August 21, 2015 — A molecular imaging biomarker is able to detect fast-growing primary prostate cancer and distinguish ...
August 20, 2015 — The ITM Group announced that its subsidiary ITG GmbH has successfully in-licensed DOTA-Zoledronate, a ...